Technologies

Medical Sciences

Title:

Antileishmanial Activity of Ampbotericin B Entrapped in Cationic Liposomal Formulation

Area:

Pharmaceutical Sciences, Life Sciences & Biotechnology, Medical Sciences

Focus Area:

Treatment of Kala azar

Patent:

IN264798

Social Benefits:

The drug-loaded liposomes have enhanced efficacy as antileishmanial agents and provide improved therapeutic index as compared to the free drug; Safe and stable. Immense therapeutic potential.

Developing Agency:

CSIR-Indian Institute of Chemical Biology (IICB), West Bengal

Technology Readiness Index:

Lab Validation

Email:

director@iicb.res.in
Website Link :http://www.iicb.res.in
Source (more info) :https://t.ly/l_sb

Brief Description

Description :

A novel method of treatment of Kala Azar using medicament comprising of antileishmanial amphotericin B encapsulated in leishmaniacidal cationic liposome.

Related Technologies